Fig. 4From: Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironmentRisk score analysis of the prognostic signature based on training and test subsets. A Kaplan–Meier survival curve analysis of BCRs between the high- and low-risk groups in the training subset. B 1-year, 3-year, and 5-year ROC curves of PCa patients in the training subset. C Risk score and survival status of each PCa patient in the training subset. D Heatmap of prognostic MTGs expression based on the risk score and clinical characteristics in the training subset. E Kaplan–Meier survival curve analysis of BCR between the high- and low-risk groups in the test subset. F 1-year, 3-year, and 5-year ROC curves of PCa patients in the test subset. G Risk score and survival status of each PCa patient in the test subset. H Heatmap of prognostic MTGs expression based on the risk score and clinical characteristics of the test subsetBack to article page